Federal Register / Vol. 83, No. 249 / Monday, December 31, 2018 / Notices 67729 

proposals for physician-focused 

payment models (PFPMs) submitted by 

individuals and stakeholder entities. All 

meetings are open to the public. 

DATES: The 2019 PTAC meetings will 

occur on the following dates: 

• Monday–Tuesday, March 11–12, 

2019, from 9:00 a.m. to 5:00 p.m. ET 

• Monday–Tuesday, June 17–18, 2019, 

from 9:00 a.m. to 5:00 p.m. ET 

• Monday–Tuesday, September 16–17, 

2019, from 9:00 a.m. to 5:00 p.m. ET 

• Monday–Tuesday, December 9–10, 

2019, from 9:00 a.m. to 5:00 p.m. ET 

Please note that times are subject to 

change. If the times change, registrants 

will be notified directly via email. 

ADDRESSES: All PTAC meetings will be 

held in the Great Hall of the Hubert H. 

Humphrey Building, 200 Independence 

Avenue SW, Washington, DC 20201. 

FOR FURTHER INFORMATION CONTACT:

Sarah Selenich, Designated Federal 

Officer, (202) 690–6870. 

SUPPLEMENTARY INFORMATION: 

Agenda and Comments. PTAC will 

hear presentations on proposed PFPMs 

that have been submitted by individuals 

and stakeholder entities. Following each 

presentation, PTAC will deliberate on 

the proposed PFPM. If PTAC completes 

its deliberation, PTAC will vote on the 

extent to which the proposed PFPM 

meets criteria established by the 

Secretary of Health and Human Services 

and on an overall recommendation to 

the Secretary. Time will be allocated for 

public comments. The agenda and other 

documents will be posted on the PTAC 

section of the ASPE website, https://

aspe.hhs.gov/ptac-physician-focusedpayment-model-technical-advisorycommittee, prior to the meeting. The 

agenda is subject to change. If the 

agenda does change, registrants will be 

notified directly via email, the website 

will be updated, and notification will be 

sent out through the PTAC email 

listserv (go to https://list.nih.gov/cgibin/wa.exe?A0=PTAC to subscribe). 

Meeting Attendance. These meetings 

are open to the public. The public may 

attend in person, via conference call, or 

view the meeting via livestream at 

www.hhs.gov/live. The conference call 

dial-in information will be sent to 

registrants prior to the meeting. Space 

may be limited, and registration is 

preferred. Registration may be 

completed online athttp://

www.cvent.com/d/gbq2tg. Name, 

organization name, and email address 

are submitted when registering. 

Registrants will receive a confirmation 

email shortly after completing the 

registration process. 

Special Accommodations. If sign 

language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact 

Angela Tejeda, no later than two weeks 

prior to the scheduled meeting. Please 

submit your requests by email to 

Angela.Tejeda@hhs.gov or by calling 

202–205–8327. 

Authority. 42 U.S.C. 1395(ee); Section 

101(e)(1) of the Medicare Access and 

CHIP Reauthorization Act of 2015; 

Section 51003(b) of the Bipartisan 

Budget Act of 2018. PTAC is governed 

by provisions of the Federal Advisory 

Committee Act, as amended (5 U.S.C. 

App.), which sets forth standards for the 

formation and use of federal advisory 

committees. 

Dated: December 19, 2018. 

Brenda Destro, 

Deputy Assistant Secretary for Planning and 

Evaluation (HSP). 

[FR Doc. 2018–28402 Filed 12–28–18; 8:45 am] 

BILLING CODE 4150–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Request for Public Comments on the 

Pain Management Best Practices InterAgency Task Force Draft Report on 

Pain Management Best Practices: 

Updates, Gaps, Inconsistencies, and 

Recommendations 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, U.S. Department of Health 

and Human Services (HHS). 

ACTION: Notice of request for public 

comments on the Draft Report on Pain 

Management Best Practices: Updates, 

Gaps, Inconsistencies, and 

Recommendations, which proposes 

updates to best practices and 

recommendations for pain management, 

including chronic and acute pain. 

SUMMARY: The Comprehensive 

Addiction and Recovery Act of 2016 

(CARA), requires that the public be 

given at least ninety (90) days to submit 

comments on any proposed updates and 

recommendations developed by the 

Pain Management Best Practices InterAgency Task Force (Task Force). The 

Task Force is requesting comments on 

the Draft Report on Pain Management 

Best Practices: Updates, Gaps, 

Inconsistencies, and Recommendations 

(hereinafter referred to as Draft Report). 

Section 101 of the CARA authorized the 

creation of the Task Force to identify 

gaps or inconsistencies, and propose 

updates to best practices and 

recommendations for pain management, 

including chronic and acute pain. The 

Secretary of HHS convened the Task 

Force in cooperation with the Secretary 

of Veterans Affairs and Secretary of 

Defense. On September 26, 2018, the 

Task Force voted on the proposed 

updates and recommendations that 

would be provided to the public for 

comment, which are included in the 

Draft Report. Once the ninety (90) day 

comment period concludes, the Task 

Force will consider comments received 

and compile a Final Report with its 

proposed updates and 

recommendations. 

DATES: Comments for consideration by 

the Task Force should be received no 

later than 5:00 p.m. Eastern Time (ET) 

on April 1, 2019. 

ADDRESSES: The Draft Report is 

available at https://www.hhs.gov/ash/ 

advisory-committees/pain/index.html. 

Written comments may be submitted by 

any of the following three methods: (1) 

Submit through the Federal 

eRulemaking Portal at http://

www.regulations.gov, Docket Number: 

HHS–OS–2018–0027, (2) Email to: 

paintaskforce@hhs.gov, or (3) Mail 

written comments to the U.S. 

Department of Health and Human 

Services, Office of the Assistant 

Secretary for Health, 200 Independence 

Avenue SW, Room 736E, Attn: Alicia 

Richmond Scott, Pain Management Best 

Practices Inter-Agency Task Force 

Designated Federal Officer, Washington, 

DC 20201. For more detailed 

instructions on submitting comments, 

see the ‘‘Instructions for Commenters’’ 

section of REQUEST FOR COMMENTS. 

FOR FURTHER INFORMATION CONTACT: 

Alicia Richmond Scott, Designated 

Federal Officer, Pain Management Best 

Practices Inter-Agency Task Force, U.S. 

Department of Health and Human 

Services, Office of the Assistant 

Secretary for Health, 200 Independence 

Avenue SW, Room 736E, Washington, 

DC 20201. Phone: 240–453–2816. Email: 

paintaskforce@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Comprehensive Addiction and Recovery 

Act of 2016 (CARA), Public Law 114– 

198, required the Secretary of Health 

and Human Services, in cooperation 

with the Secretaries of Defense and 

Veterans Affairs, to convene the Task 

Force no later than two years after the 

CARA enactment. The Task Force is 

required to propose updates on best 

practices and recommendations to 

address gaps or inconsistencies for pain 

management, including chronic and 

acute pain, and submit such updates 

and recommendations to relevant 

Federal agencies and the general public. 

The duties of the Task Force are to: 

• Identify, review, determine, and 

propose updates to gaps or 

inconsistencies between best practices 


khammond on DSK30JT082PROD with NOTICES
67730 Federal Register / Vol. 83, No. 249 / Monday, December 31, 2018 / Notices 

for pain management, taking into 

consideration: 

—Existing pain management research 

and other relevant research; 

—Recommendations from relevant 

conferences and existing evidencebased guidelines; 

—Ongoing efforts at the state and local 

level and by medical professional 

organizations to develop improved 

pain management strategies; 

—The management of high-risk 

populations who receive opioids in 

the course of medical care, other than 

for pain management; 

—The 2016 Guideline for Prescribing 

Opioids for Chronic Pain issued by 

the CDC; and 

—Private sector, State, and local 

government efforts related to pain 

management and prescribing pain 

medication. 

• Provide the public with at least 

ninety (90) days to submit comments on 

any proposed updates and 

recommendations. 

• Develop a strategy for 

dissemination of information on best 

practices for pain management to 

stakeholders, if appropriate. 

The Draft Report highlights the 

progress made towards identifying, 

reviewing, and determining whether 

there are gaps in or inconsistencies 

between best practices for pain 

management (including chronic and 

acute pain) developed or adopted by 

Federal agencies. It includes the Task 

Force’s proposed updates to best 

practices and recommendations on 

addressing gaps or inconsistencies. On 

September 26, 2018, the Task Force 

voted on the proposed updates and 

recommendations that would be 

provided to the public for comment. 

The proposed updates and 

recommendations are included in the 

Draft Report. Once the ninety (90) day 

comment period concludes, the Task 

Force will consider comments received 

and compile a Final Recommendations 

Report with its proposed updates and 

recommendations. 

Request for Comment: The goal of this 

Request for Comment is to solicit 

feedback on the Draft Report, which 

includes the Task Force’s proposed 

updates and recommendations. The 

Task Force invites comment on the full 

range of issues that may be relevant to 

the proposed updates and 

recommendations. 

Instructions for Commenters: Written 

comments should not exceed three 

pages in length. To assist with the 

review of public comments, the public 

should cite a specific section, gap and/ 

or recommendation of the report (e.g., 

acute pain, gap 2 or recommendation 

2b) for which the comments are related. 

Comments that contain references to 

studies, research, and other empirical 

data that are not widely available 

should include copies of the referenced 

materials with the submitted comments. 

Comments submitted by email should 

be machine-readable and should not be 

copy-protected. Responders are 

encouraged to include the name of the 

person or organization filing the 

comment, in case follow-up is needed, 

as well as a page number on each page 

of their submission(s). 

Written comments may be submitted 

by any of the following three methods: 

(1) Submit through the Federal 

eRulemaking Portal at http://

www.regulations.gov, Docket Number: 

HHS–OS–2018–0027, (2) Email to: 

paintaskforce@hhs.gov, or (3) Mail 

written comments to the U.S. 

Department of Health and Human 

Services, Office of the Assistant 

Secretary for Health, 200 Independence 

Avenue SW, Room 736E, Attn: Alicia 

Richmond Scott, Pain Management Task 

Force Designated Federal Officer, 

Washington, DC 20201. 

Dated: December 11, 2018. 

Vanila M. Singh, 

Chief Medical Officer, Office of the Assistant 

Secretary for Health. 

[FR Doc. 2018–28403 Filed 12–28–18; 8:45 am] 

BILLING CODE 4150–28–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1105] 

Certain Programmable Logic 

Controller (PLCs), Components 

Thereof, and Products Containing 

Same; Commission Determination Not 

To Review an Initial Determination 

Terminating the Investigation in Its 

Entirety; Termination of Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has determined not to 

review an initial determination (‘‘ID’’) 

(Order No. 24) granting a motion by 

Complainant Radwell International, 

Inc., of Willingboro, New Jersey 

(‘‘Radwell’’) to terminate the abovecaptioned investigation in its entirety by 

reason of withdrawal of its complaint. 

The investigation is hereby terminated. 

FOR FURTHER INFORMATION CONTACT: Carl 

P. Bretscher, Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436, telephone 202– 

205–2382. Copies of non-confidential 

documents filed in connection with this 

investigation are or will be available for 

inspection during official business 

hours (8:45 a.m. to 5:15 p.m.) in the 

Office of the Secretary, U.S. 

International Trade Commission, 500 E 

Street SW, Washington, DC 20436, 

telephone 202–205–2000. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server (https://www.usitc.gov). 

The public record for this investigation 

may be viewed on the Commission’s 

electronic docket (EDIS) at https://

edis.usitc.gov. Hearing-impaired 

persons are advised that information on 

this matter can be obtained by 

contacting the Commission’s TDD 

terminal on 202–205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on March 29, 2018, based on a 

Complaint filed by Radwell. 83 FR 

13515–16 (Mar. 29, 2018). The 

Complaint alleges violations of Section 

337 of the Tariff Act of 1930, as 

amended, 19 U.S.C. 1337, in the 

importation into the United States, sale 

for importation, and sale within the 

United States after importation of 

certain programmable logic controllers 

(‘‘PLCs’’), components thereof, and 

products containing same by reason of: 

(1) A conspiracy to fix resale prices in 

violation of Section 1 of the Sherman 

Act; (2) a conspiracy to boycott resellers 

in violation of Section 1 of the Sherman 

Act; and (3) monopolization in violation 

of Section 2 of the Sherman Act, the 

threat or effect of which is to destroy or 

substantially injure a domestic industry 

in the United States, or to restrain or 

monopolize trade and commerce in the 

United States. Id. The notice of 

investigation names Rockwell 

Automation, Inc. (‘‘Rockwell’’) of 

Milwaukee, Wisconsin as Respondent. 

Id. The Office of Unfair Import 

Investigations (‘‘OUII’’) was also named 

as a party to the investigation. Id. Nonparty North Coast Electric Company was 

later added as an intervenor. Comm’n 

Notice (July 27, 2018) (aff’g Order No. 

10 (July 9, 2018)), 83 FR 37516 (Aug. 1, 

2018). 

On November 8, 2018, Radwell filed 

an opposed motion to terminate the 

investigation in its entirety by 

withdrawal of its complaint, pursuant to 

Commission Rule 210.21(a)(1), 19 CFR 

210.21(a)(1). On November 19, 2018, 

Rockwell filed an opposition to the 

motion. On the same date, OUII filed a 

response supporting Radwell’s motion. 


khammond on DSK30JT082PROD with NOTICES